Adherence expresses the patient's degree of commitment to the therapeutic process. It's necessary for professionals to know how to evaluate it in order to plan more effective conducts. This study aims to perform a systematic review of the adherence of patients with a dysphonia setting to voice therapy programs. This review was carried out on the PubMed, Lilacs, Scopus, and Cochrane Library databases, using a search strategy related to the subject of the study. The selection included studies that assessed the adherence of patients with dysphonia to voice therapy using an instrument created for the study or previously validated. Of 1987 publications, 35 were included, of which 14 were excluded for not fitting the eligibility criteria of this review, leaving a total of 21 papers, which were analyzed in full and went through qualitative analysis. The strategies found for the assessment of adherence were the conclusion of the therapy plan, patient self-report, and the use of the URICA-VOICE scale. Therapy conclusion was the most commonly used of the strategies, which showed low adherence to voice therapy. This result shows that instruments like the URICA-VOICE scale measure in a more detailed manner which stage the patient finds himself at the moment of the evaluation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvoice.2019.04.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Cochlear implantation is an effective method of auditory rehabilitation. Nevertheless, the results show individual variations depending on several factors.
Aim: To evaluate cochlear implantation results based on the APCEI profile (Acceptance, Perception, Comprehension, Oral Expression and Intelligibility) and audiometric results.
Assessment and management of late radiation-associated dysphagia after treatment for head and neck cancer: A scoping review and survey of UK speech and language therapists.
Int J Lang Commun Disord
January 2025
School of Health Science, Univeristy of Liverpool University, Liverpool, UK.
Background: Late side effects of head and neck cancer treatment commonly affect swallowing function. Late radiation-associated dysphagia (late-RAD) often presents years post-treatment when patients have been discharged from their multidisciplinary team. Timely symptom management may provide important physical and emotional support, potentially reducing the overall healthcare burden.
View Article and Find Full Text PDFContagion comeback: unravelling the measles outbreak across the USA.
Front Public Health
January 2025
Atish Dipankar University of Science and Technology, Dhaka, Bangladesh.
Measles, a highly contagious respiratory illness caused by the measles virus (MeV), poses significant global and national public health challenges despite advancements in vaccination efforts. Though measles was declared eliminated in the United States in 2000, recent years have seen a resurgence of cases, particularly in under-vaccinated communities. This resurgence is compounded by factors such as vaccine hesitancy, the impact of the COVID-19 pandemic on immunization rates, and international travel introducing new cases from endemic regions.
View Article and Find Full Text PDFCommunity Involvement in COVID-19 Management: A Central Component of Comprehensive Public Health Responses to COVID-19 and Future Health Crises.
Disaster Med Public Health Prep
January 2025
Department of Operating Room, Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran.
The COVID-19 pandemic is highly contagious, with symptoms such as myalgia, cough, fever, and weakness, posing a greater risk to older adults and individuals with chronic conditions. Effective management requires meaningful community involvement to reduce health inequalities and ensure people-centered health care. Engaging local voices, including leaders, health care professionals, and vulnerable populations, enhances decision-making, transparent communication, and resource mobilization.
View Article and Find Full Text PDFEvolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases.
Value Health
December 2024
CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.
Objective: Recent scientific breakthroughs have propelled the development of disease-modifying and potentially curative cell and gene therapies (CGTs) for rare diseases, including those diseases previously considered untreatable. However, the unique characteristics of CGTs pose challenges for the traditional methods of therapy value determination, reimbursement, and outcome evaluation used by regulatory and assessment agencies for product approval and market access. Notably, CGTs are one-time or short-course treatments, often first-in-class (precluding direct comparisons with effective alternatives), and have health benefits that are largely realized over time.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!